Luminex Corporation Company Profile (NASDAQ:LMNX)

About Luminex Corporation

Luminex Corporation logoLuminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to various types of testing laboratories. The Company's assay products are focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: LMNX
  • CUSIP: 55027E10
Key Metrics:
  • Previous Close: $18.25
  • 50 Day Moving Average: $20.05
  • 200 Day Moving Average: $20.98
  • 52-Week Range: $42,768,000.00 - $17.57
  • Trailing P/E Ratio: 57.03
  • Foreward P/E Ratio: 30.93
  • P/E Growth: 1.10
  • Market Cap: $780.52M
  • Outstanding Shares: 42,768,000
  • Beta: 0.59
Profitability:
  • Net Margins: 5.10%
  • Return on Equity: 5.53%
  • Return on Assets: 5.04%
Debt:
  • Current Ratio: 4.32%
  • Quick Ratio: 3.31%
Additional Links:
Companies Related to Luminex Corporation:

Analyst Ratings

Consensus Ratings for Luminex Corporation (NASDAQ:LMNX) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $21.33 (16.89% upside)

Analysts' Ratings History for Luminex Corporation (NASDAQ:LMNX)
Show:
DateFirmActionRatingPrice TargetDetails
2/14/2017Jefferies Group LLCReiterated RatingHold$20.00View Rating Details
2/7/2017Piper Jaffray CompaniesLower Price TargetNeutral$20.00 -> $19.00View Rating Details
2/7/2017William BlairReiterated RatingMarket PerformView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingSell$18.00View Rating Details
10/12/2016Avondale PartnersInitiated CoverageOutperform$27.00View Rating Details
8/18/2016J P Morgan Chase & CoUpgradeUnderweight -> Neutral$18.00 -> $22.00View Rating Details
5/3/2016Leerink SwannReiterated RatingHold$22.00View Rating Details
8/4/2015WedbushUpgradeNeutral -> Outperform$19.00 -> $22.00View Rating Details
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$17.00 -> $18.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Luminex Corporation (NASDAQ:LMNX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2017        
2/6/2017Q4 2016$0.09$0.11$70.92 million$72.30 millionViewListenView Earnings Details
10/31/2016Q316$0.12$0.21$68.90 million$71.20 millionViewListenView Earnings Details
7/28/2016Q216$0.15$0.33$61.20 million$64.20 millionViewListenView Earnings Details
5/2/2016Q116$0.14$0.29$60.98 million$63.00 millionViewListenView Earnings Details
2/1/2016Q415$0.15$0.56$60.16 million$60.40 millionViewN/AView Earnings Details
11/2/2015Q315$0.11$0.22$57.24 million$60.60 millionViewListenView Earnings Details
8/3/2015Q215$0.11$0.27$57.01 million$58.90 millionViewListenView Earnings Details
5/4/2015Q115$0.12$0.23$56.50 million$57.70 millionViewListenView Earnings Details
2/2/2015Q414$0.12$0.19$58.31 million$58.10 millionViewListenView Earnings Details
10/27/2014Q314$0.10$0.27$56.60 million$56.68 millionViewListenView Earnings Details
7/28/2014Q214$0.10$0.20$55.90 million$55.50 millionViewListenView Earnings Details
4/28/2014Q114$0.12$0.24$55.31 million$56.60 millionViewListenView Earnings Details
2/3/2014Q413$0.07$0.21$56.63 million$55.20 millionViewListenView Earnings Details
11/4/2013Q313$0.11$0.02$54.67 million$50.80 millionViewListenView Earnings Details
7/29/2013Q2 2013$0.10$0.17$54.16 million$54.30 millionViewListenView Earnings Details
4/29/2013Q1 2013$0.08$0.19$51.94 million$53.20 millionViewListenView Earnings Details
2/4/2013Q4 2012$0.08$0.12$54.09 million$55.53 millionViewListenView Earnings Details
10/29/2012Q312$0.06$0.04$51.26 million$50.00 millionViewN/AView Earnings Details
7/30/2012$0.08$0.07ViewN/AView Earnings Details
4/30/2012$0.09$0.08ViewN/AView Earnings Details
2/6/2012$0.07$0.11ViewN/AView Earnings Details
11/1/2011$0.05$0.05ViewN/AView Earnings Details
8/8/2011$0.06$0.11ViewN/AView Earnings Details
5/9/2011$0.06$0.11ViewN/AView Earnings Details
2/7/2011$0.05$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Luminex Corporation (NASDAQ:LMNX)
Current Year EPS Consensus Estimate: $0.29 EPS
Next Year EPS Consensus Estimate: $0.59 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.13$0.14$0.14
Q2 20163$0.14$0.19$0.17
Q3 20163$0.04$0.19$0.12
Q4 20163$0.01$0.18$0.12
Q1 20171$0.09$0.09$0.09
Q2 20171$0.10$0.10$0.10
Q3 20171$0.12$0.12$0.12
Q4 20171$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Luminex Corporation (NASDAQ:LMNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Luminex Corporation (NASDAQ:LMNX)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 79.45%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/26/2017G Walter Loewenbaum IIDirectorSell20,000$19.75$395,000.00View SEC Filing  
1/19/2017G Walter Loewenbaum IIDirectorSell20,000$19.82$396,400.00View SEC Filing  
1/12/2017G Walter Loewenbaum IIDirectorSell20,000$20.43$408,600.00View SEC Filing  
1/5/2017G Walter Loewenbaum IIDirectorSell20,000$20.32$406,400.00View SEC Filing  
12/29/2016G Walter Loewenbaum IIDirectorSell20,000$20.27$405,400.00View SEC Filing  
11/28/2016G Walter Loewenbaum IIDirectorSell50,000$20.57$1,028,500.00View SEC Filing  
11/15/2016Kevin M McnamaraDirectorSell12,000$21.03$252,360.00View SEC Filing  
11/3/2016Harriss T. CurrieSVPBuy4,100$18.20$74,620.00View SEC Filing  
11/3/2016Nachum ShamirCEOBuy6,000$18.22$109,320.00View SEC Filing  
1/4/2016G Walter Loewenbaum IIDirectorSell41,056$20.53$842,879.68View SEC Filing  
12/31/2015G Walter Loewenbaum IIDirectorSell18,944$21.65$410,137.60View SEC Filing  
12/16/2015Russell W. BradleyCMOSell6,514$22.75$148,193.50View SEC Filing  
5/28/2015Nachum ShamirCEOBuy6,000$16.73$100,380.00View SEC Filing  
5/27/2015G Walter Loewenbaum IIDirectorBuy38,966$16.71$651,121.86View SEC Filing  
2/5/2015Fred C Goad JrDirectorSell25,000$15.46$386,500.00View SEC Filing  
10/8/2014Russell W BradleySVPSell5,000$20.50$102,500.00View SEC Filing  
5/15/2014Patrick BalthropCEOSell70,000$17.69$1,238,300.00View SEC Filing  
5/12/2014Kevin McnamaraDirectorSell5,000$17.95$89,750.00View SEC Filing  
5/9/2014Jim KeverDirectorSell5,000$17.52$87,600.00View SEC Filing  
5/7/2014Patrick BalthropCEOSell32,575$17.63$574,297.25View SEC Filing  
5/6/2014Patrick BalthropCEOSell60,000$18.28$1,096,800.00View SEC Filing  
5/2/2014Fred Goad, Jr.DirectorSell50,000$18.86$943,000.00View SEC Filing  
5/2/2014Patrick BalthropCEOSell55,000$19.05$1,047,750.00View SEC Filing  
5/1/2014David ReiterSVPSell15,000$19.09$286,350.00View SEC Filing  
5/1/2014Harriss CurrieCFOSell11,000$19.08$209,880.00View SEC Filing  
9/23/2013Harriss CurrieCFOSell30,000$19.88$596,400.00View SEC Filing  
9/17/2013Harriss CurrieCFOSell30,000$19.87$596,100.00View SEC Filing  
9/13/2013Michael PintekSVPSell3,000$20.00$60,000.00View SEC Filing  
8/30/2013G Walter Loewenbaum IIDirectorBuy6,034$20.62$124,421.08View SEC Filing  
8/28/2013G Walter Loewenbaum IIDirectorBuy20,000$20.76$415,200.00View SEC Filing  
8/16/2013Timothy DehneVPSell32,297$20.66$667,256.02View SEC Filing  
8/15/2013G Walter Loewenbaum IIDirectorBuy10,000$20.82$208,200.00View SEC Filing  
8/14/2013Timothy DehneVPSell1,793$21.21$38,029.53View SEC Filing  
8/9/2013G Walter Loewenbaum IIDirectorBuy4,600$21.17$97,382.00View SEC Filing  
8/2/2013G Walter Loewenbaum IIDirectorBuy27,000$20.01$540,270.00View SEC Filing  
8/2/2013Patrick J BalthropCEOSell68,048$20.01$1,361,640.48View SEC Filing  
8/1/2013David S ReiterSVPSell15,000$20.00$300,000.00View SEC Filing  
8/1/2013Thomas W EricksonDirectorSell20,000$20.00$400,000.00View SEC Filing  
5/24/2013Fred C Goad JrDirectorBuy11,250$18.25$205,312.50View SEC Filing  
5/17/2013G Walter Loewenbaum IIDirectorBuy13,000$18.37$238,810.00View SEC Filing  
5/16/2013Fred C Goad JrDirectorBuy8,000$18.18$145,440.00View SEC Filing  
5/15/2013G Walter Loewenbaum IIDirectorBuy39,500$18.32$723,640.00View SEC Filing  
5/10/2013David S ReiterSVPSell10,000$18.26$182,600.00View SEC Filing  
5/10/2013G Walter Loewenbaum IIDirectorBuy19,000$18.13$344,470.00View SEC Filing  
5/9/2013G Walter Loewenbaum IIDirectorBuy28,300$17.21$487,043.00View SEC Filing  
5/7/2013G Walter Loewenbaum IIDirectorBuy64,935$17.17$1,114,933.95View SEC Filing  
5/3/2013G Walter Loewenbaum IIDirectorBuy24,765$17.02$421,500.30View SEC Filing  
9/4/2012David S ReiterVPSell10,000$20.00$200,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Luminex Corporation (NASDAQ:LMNX)
DateHeadline
capitalcube.com logoLuminex Corp. :LMNX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017 (NASDAQ:LMNX)
www.capitalcube.com - February 9 at 7:17 PM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:LMNX)
us.rd.yahoo.com - February 9 at 12:09 AM
capitalcube.com logoLuminex Corp. :LMNX-US: Earnings Analysis: 2016 By the Numbers : February 8, 2017 (NASDAQ:LMNX)
www.capitalcube.com - February 8 at 7:06 PM
us.rd.yahoo.com logoEdited Transcript of LMNX earnings conference call or presentation 6-Feb-17 9:30pm GMT (NASDAQ:LMNX)
us.rd.yahoo.com - February 7 at 7:37 PM
streetinsider.com logoAfter-Hours Stock Movers 02/06: (ALSN) (FN) (GPS) Higher; (FMC) (KN) (YRCW) Lower (more...) (NASDAQ:LMNX)
www.streetinsider.com - February 6 at 11:27 PM
News IconWhat analysts think about the future of Luminex Corporation’s (LMNX) business? (NASDAQ:LMNX)
simplywall.st - February 6 at 11:27 PM
seekingalpha.com logoLuminex's (LMNX) CEO Homi Shamir on Q4 2016 Results - Earnings Call Transcript (NASDAQ:LMNX)
seekingalpha.com - February 6 at 11:27 PM
seekingalpha.com logoLuminex Q4 revenues up 20%; earnings down 117%; cash flow ops up 3%; shares down 2% after hours (NASDAQ:LMNX)
seekingalpha.com - February 6 at 6:42 PM
us.rd.yahoo.com logoLuminex Corporation Reports Fourth Quarter And Full Year 2016 Results (NASDAQ:LMNX)
us.rd.yahoo.com - February 6 at 6:25 PM
sg.finance.yahoo.com logoLuminex reports 4Q loss (NASDAQ:LMNX)
sg.finance.yahoo.com - February 6 at 6:25 PM
biz.yahoo.com logoQ4 2016 Luminex Corp Earnings Release - After Market Close (NASDAQ:LMNX)
biz.yahoo.com - February 6 at 10:10 AM
biz.yahoo.com logoLuminex Corp Earnings Call scheduled for 4:30 pm ET today (NASDAQ:LMNX)
biz.yahoo.com - February 6 at 10:10 AM
finance.yahoo.com logoShould You Sell Luminex (LMNX) Before Earnings? (NASDAQ:LMNX)
finance.yahoo.com - February 3 at 7:00 PM
News IconDirector of Luminex Corporation (NASDAQ:LMNX), Loewenbaum G Walter Ii, sells 20,000 shares worth $395,002 (NASDAQ:LMNX)
empowerednews.net - January 30 at 6:59 PM
News IconVillere St Denis J & Co LLC Raised Its Gulfport Energy Corp (GPOR) Holding by $7.75 Million (NASDAQ:LMNX)
randolphguide.com - January 26 at 8:03 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : January 18, 2017 (NASDAQ:LMNX)
us.rd.yahoo.com - January 18 at 11:51 PM
us.rd.yahoo.com logoCoverage initiated on Luminex by Deutsche Bank (NASDAQ:LMNX)
us.rd.yahoo.com - January 18 at 11:51 PM
News IconDirector of Luminex Corporation (NASDAQ:LMNX), Loewenbaum G Walter Ii, sells 20,000 shares worth $408,532 (NASDAQ:LMNX)
empowerednews.net - January 14 at 12:36 AM
seekingalpha.com logoLuminex (LMNX) presents at 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:LMNX)
seekingalpha.com - January 12 at 6:50 PM
bizjournals.com logoAustin's Luminex lays off 50, still has high hopes for 2017 (NASDAQ:LMNX)
www.bizjournals.com - January 10 at 7:13 PM
News IconDirector of Luminex Corporation (NASDAQ:LMNX), Loewenbaum G Walter Ii, sells 20,000 shares worth $406,392 (NASDAQ:LMNX)
empowerednews.net - January 10 at 12:04 AM
marketexclusive.com logoLUMINEX CORPORATION (NASDAQ:LMNX) Files An 8-K Results of Operations and Financial Condition (NASDAQ:LMNX)
marketexclusive.com - January 10 at 12:04 AM
us.rd.yahoo.com logoLuminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance; To Present at 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:LMNX)
us.rd.yahoo.com - January 9 at 7:03 PM
us.rd.yahoo.com logo8:32 am Luminex guides Q4 revenue slightly above consensus; guides 2017 revenue above consensus (NASDAQ:LMNX)
us.rd.yahoo.com - January 9 at 7:03 PM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S (NASDAQ:LMNX)
biz.yahoo.com - January 9 at 7:03 PM
bizjournals.com logoA primer for one of nation's largest health care conferences, Austin companies included (NASDAQ:LMNX)
www.bizjournals.com - January 9 at 7:03 PM
seekingalpha.com logoLuminex announces preliminary revenue for Q4 and issues 2017 revenue guidance (NASDAQ:LMNX)
seekingalpha.com - January 9 at 3:57 PM
streetinsider.com logoLuminex Corp. (LMNX) Gains FDA Clearance for ARIES GBS Assay (NASDAQ:LMNX)
www.streetinsider.com - January 5 at 7:44 PM
News IconLuminex Corp LMNX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:LMNX)
www.bioportfolio.com - January 5 at 7:44 PM
finance.yahoo.com logoLuminex Corporation Receives FDA Clearance for ARIES® GBS Assay (NASDAQ:LMNX)
finance.yahoo.com - January 4 at 7:09 PM
finance.yahoo.com logo8:01 am Luminex receives FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization in pregnant women (NASDAQ:LMNX)
finance.yahoo.com - January 4 at 7:09 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : January 2, 2017 (NASDAQ:LMNX)
www.capitalcube.com - January 2 at 9:49 AM
capitalcube.com logoLuminex Corp. – Value Analysis (NASDAQ:LMNX) : December 27, 2016 (NASDAQ:LMNX)
www.capitalcube.com - December 27 at 6:17 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : December 23, 2016 (NASDAQ:LMNX)
www.capitalcube.com - December 23 at 6:31 PM
capitalcube.com logoETFs with exposure to Luminex Corp. : December 8, 2016 (NASDAQ:LMNX)
www.capitalcube.com - December 8 at 6:53 PM
News IconLuminex Corporation (LMNX): Are Hedge Funds Right About This Stock? (NASDAQ:LMNX)
feedproxy.google.com - December 8 at 2:43 PM
zacks.com logoLuminex Awarded R&D 100 for ARIES Systems in November (NASDAQ:LMNX)
www.zacks.com - December 6 at 10:09 AM
News IconLuminex Corporation LMNX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:LMNX)
www.bioportfolio.com - December 5 at 10:34 AM
finance.yahoo.com logoLuminex wins R&D 100 Award for ARIES Systems (NASDAQ:LMNX)
finance.yahoo.com - December 5 at 10:34 AM
News IconLuminex Corporation LMNX Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:LMNX)
www.bioportfolio.com - November 21 at 11:08 AM
capitalcube.com logoLuminex Corp. :LMNX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NASDAQ:LMNX)
www.capitalcube.com - November 18 at 5:34 PM
finance.yahoo.com logoARIES System and Flu A/B & RSV Assay Evaluated by Erasmus MC in New Publication (NASDAQ:LMNX)
finance.yahoo.com - November 17 at 9:36 AM
capitalcube.com logoETFs with exposure to Luminex Corp. : November 15, 2016 (NASDAQ:LMNX)
www.capitalcube.com - November 15 at 6:33 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : November 14, 2016 (NASDAQ:LMNX)
www.capitalcube.com - November 14 at 10:00 AM
seekingalpha.com logoLuminex's (LMNX) CEO Homi Shamir on Q3 2016 Results - Earnings Call Transcript (NASDAQ:LMNX)
seekingalpha.com - November 2 at 6:11 PM
News IconLuminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance (NASDAQ:LMNX)
www.pharmiweb.com - November 2 at 9:31 AM
sg.finance.yahoo.com logoLuminex misses 3Q profit forecasts (NASDAQ:LMNX)
sg.finance.yahoo.com - October 31 at 6:00 PM
biz.yahoo.com logoQ3 2016 Luminex Corp Earnings Release - After Market Close (NASDAQ:LMNX)
biz.yahoo.com - October 31 at 12:35 PM
finance.yahoo.com logoShould You Buy Luminex (LMNX) Ahead of Earnings? (NASDAQ:LMNX)
finance.yahoo.com - October 27 at 10:45 AM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : October 18, 2016 (NASDAQ:LMNX)
www.capitalcube.com - October 18 at 11:11 AM

Social

What is Luminex Corporation's stock symbol?

Luminex Corporation trades on the NASDAQ under the ticker symbol "LMNX."

Where is Luminex Corporation's stock going? Where will Luminex Corporation's stock price be in 2017?

7 brokerages have issued 1 year price targets for Luminex Corporation's shares. Their predictions range from $18.00 to $27.00. On average, they anticipate Luminex Corporation's share price to reach $21.33 in the next year.

When will Luminex Corporation announce their earnings?

Luminex Corporation is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

What are analysts saying about Luminex Corporation stock?

Here are some recent quotes from research analysts about Luminex Corporation stock:

  • Piper Jaffray Companies analysts commented, "Luminex announced 4Q16 revenue of $72.3M, in line with preliminary results. Adj. EPS of $0.06 missed the Street's $0.13 estimate. Results in the quarter reflect strong consumables growth, somewhat offset by lighter instrument sales. Management reaffirmed FY17 revenue guidance of $295M-$305M and provided 1Q17 revenue guidance in line with the Street ($73M-$75M; Street: $74.2M). Revenue guidance appears achievable, but we believe shares are fairly valued. We remain Neutral with a $19 price target (was $20) based on ~2.1x FY18 EV/Rev (unchanged) on our revised estimates." (2/7/2017)
  • According to Zacks Investment Research, "In the past six months, Luminex’s share price over performed the broader industry trend. However, in the last 30 days, earnings estimates have been moved downwards reflecting sluggish third quarter performance. We note that, Luminex reported dismal third quarter 2016 results, missing the Zacks Consensus Estimates on both lines. However, the company raised its revenue guidance for the full-year of 2016. We believe that Luminex's Assay business will be its key growth driver over the long term. We are also optimistic with regard to the company’s products – ARIES and NxTAG RPP, which represent a major revenue opportunity for Luminex. These products will considerably expand the company’s addressable market in the long run. Moreover, the recently completed Nanosphere acquisition expands Luminex's product portfolio. We are also bullish on the company’s promising financial position, which is with no debt, at the end of the" (11/29/2016)

Who owns Luminex Corporation stock?

Luminex Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.87%), Renaissance Technologies LLC (3.15%), State Street Corp (2.05%), Fred Alger Management Inc. (1.40%), GSA Capital Partners LLP (0.52%) and Wall Street Access Asset Management LLC (0.51%). Company insiders that own Luminex Corporation stock include G Walter Loewenbaum II, Harriss T Currie, Kevin M Mcnamara, Nachum Shamir and Russell W Bradley.

Who sold Luminex Corporation stock? Who is selling Luminex Corporation stock?

Luminex Corporation's stock was sold by a variety of institutional investors in the last quarter, including Systematic Financial Management LP, Fred Alger Management Inc., Oxford Asset Management, Wall Street Access Asset Management LLC, Raymond James Financial Services Advisors Inc., AQR Capital Management LLC, GSA Capital Partners LLP and O Shaughnessy Asset Management LLC. Company insiders that have sold Luminex Corporation stock in the last year include G Walter Loewenbaum II and Kevin M Mcnamara.

Who bought Luminex Corporation stock? Who is buying Luminex Corporation stock?

Luminex Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Russell Investments Group Ltd., State Street Corp, Congress Asset Management Co. MA, Guggenheim Capital LLC, Martingale Asset Management L P, Trexquant Investment LP and Renaissance Technologies LLC. Company insiders that have bought Luminex Corporation stock in the last two years include G Walter Loewenbaum II, Harriss T Currie and Nachum Shamir.

How do I buy Luminex Corporation stock?

Shares of Luminex Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Luminex Corporation stock cost?

One share of Luminex Corporation stock can currently be purchased for approximately $18.25.

Luminex Corporation (NASDAQ:LMNX) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

Earnings History Chart

Earnings by Quarter for Luminex Corporation (NASDAQ:LMNX)

Dividend History Chart

Dividend Payments by Quarter for Luminex Corporation (NASDAQ:LMNX)

Last Updated on 2/20/2017 by MarketBeat.com Staff